Cochrane Abstracts
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Short‐acting Beta2‐agonists Versus Ipratropium for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434409/all/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed 03 June 2023.
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/all/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed June 3, 2023.
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/all/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
Inhaled Short‐acting Beta2‐agonists Versus Ipratropium for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/all/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions)
ID - 434409
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/all/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
